Table 6

Estimated regional period parameters (Tr) for 2000 by cancer site and sex

Oral

Oesophagus

Stomach

Colon and rectum

Liver

Pancreas


Region

Male

Female

Male

Female

Male

Female

Male

Female

Male

Female

Male

Female


AfrD

2.132

1.493

1.072

1.119

1.070

1.198

1.892

1.794

1.050

1.102

1.003

1.049

AfrE

2.111

1.486

1.065

1.117

1.069

1.195

1.880

1.784

1.050

1.101

1.003

1.048

AmrA

0.887

0.873

0.975

0.973

0.965

0.930

0.845

0.859

0.985

1.000

1.002

0.994

AmrB

1.747

1.357

1.017

1.087

1.047

1.140

1.663

1.590

1.046

1.080

1.003

1.037

AmrD

1.984

1.443

1.040

1.107

1.061

1.177

1.809

1.720

1.049

1.094

1.003

1.044

EmrB

1.774

1.368

1.019

1.089

1.049

1.144

1.681

1.606

1.046

1.082

1.003

1.038

EmrD

2.005

1.451

1.043

1.109

1.063

1.180

1.821

1.731

1.049

1.095

1.003

1.045

EurA

1.122

1.059

0.985

1.017

0.997

1.011

1.160

1.141

1.017

1.030

1.002

1.010

EurB1

1.797

1.376

1.021

1.091

1.050

1.148

1.695

1.618

1.047

1.083

1.003

1.038

EurB2

2.069

1.472

1.054

1.114

1.066

1.189

1.857

1.763

1.050

1.099

1.003

1.047

EurC

1.868

1.402

1.027

1.097

1.055

1.159

1.739

1.658

1.048

1.087

1.003

1.041

SearB

1.933

1.426

1.033

1.103

1.058

1.169

1.778

1.693

1.049

1.091

1.003

1.043

SearD

2.127

1.491

1.071

1.118

1.070

1.197

1.890

1.792

1.050

1.102

1.003

1.048

WprA

0.979

0.958

0.979

0.993

0.980

0.967

0.989

0.987

1.001

1.014

1.002

1.001

WprB1

1.990

1.445

1.041

1.108

1.062

1.178

1.812

1.723

1.049

1.095

1.003

1.044

WprB2

2.095

1.481

1.061

1.116

1.068

1.193

1.872

1.776

1.050

1.100

1.003

1.048

WprB3

1.967

1.437

1.038

1.106

1.060

1.174

1.799

1.711

1.049

1.093

1.003

1.044


Lung

Bladder

Non-Hodgkin lymphoma

Hodgkin lymphoma

Multiple myeloma

Leukaemia


Region

Male

Female

Male

Female

Male

Female

Male

Female

Male

Female

Male

Female


AfrD

1.141

1.212

3.526

2.844

1.466

1.581

2.176

2.419

1.081

1.213

1.539

1.493

AfrE

1.139

1.210

3.492

2.819

1.459

1.574

2.160

2.399

1.080

1.209

1.532

1.486

AmrA

0.984

0.995

0.493

0.653

0.891

0.913

0.676

0.557

0.945

0.907

0.880

0.875

AmrB

1.107

1.165

2.864

2.365

1.340

1.435

1.849

2.013

1.052

1.146

1.395

1.358

AmrD

1.129

1.195

3.284

2.669

1.420

1.528

2.057

2.271

1.070

1.188

1.487

1.444

EmrB

1.110

1.169

2.915

2.402

1.350

1.447

1.874

2.044

1.054

1.151

1.406

1.368

EmrD

1.131

1.198

3.320

2.695

1.427

1.536

2.075

2.293

1.072

1.192

1.494

1.451

EurA

1.031

1.061

1.405

1.312

1.064

1.114

1.127

1.117

0.986

0.999

1.078

1.061

EurB1

1.112

1.172

2.956

2.432

1.358

1.456

1.894

2.069

1.056

1.155

1.415

1.377

EurB2

1.136

1.205

3.424

2.771

1.447

1.559

2.126

2.357

1.077

1.203

1.517

1.472

EurC

1.118

1.181

3.083

2.524

1.382

1.484

1.957

2.148

1.061

1.168

1.443

1.403

SearB

1.124

1.189

3.197

2.606

1.403

1.509

2.014

2.217

1.067

1.180

1.468

1.426

SearD

1.141

1.212

3.519

2.839

1.464

1.580

2.173

2.415

1.081

1.212

1.538

1.492

WprA

1.006

1.025

0.908

0.953

0.970

1.004

0.881

0.812

0.964

0.949

0.970

0.959

WprB1

1.129

1.196

3.294

2.676

1.422

1.530

2.062

2.277

1.071

1.189

1.489

1.446

WprB2

1.138

1.208

3.468

2.802

1.455

1.569

2.148

2.384

1.079

1.207

1.527

1.481

WprB3

1.127

1.193

3.255

2.648

1.414

1.522

2.043

2.253

1.069

1.186

1.480

1.438


Melanoma

Miscellaneous

Breast

Cervix

Uterus

Ovary

Prostate

GDP Per capita


Region

Male

Female

Male

Female

Female

Female

Female

Female

Male


AfrD

3.811

6.596

1.720

1.741

2.748

1.647

1.896

1.261

5.559

1,158

AfrE

3.775

6.174

1.709

1.731

2.725

1.638

1.885

1.247

5.505

1,465

AmrA

0.452

0.819

0.718

0.849

0.657

0.845

0.881

1.064

0.647

28,910

AmrB

3.093

3.311

1.501

1.546

2.292

1.472

1.674

1.149

4.487

7,217

AmrD

3.550

4.680

1.640

1.670

2.582

1.583

1.815

1.196

5.168

3,367

EmrB

3.149

3.431

1.518

1.561

2.327

1.485

1.692

1.153

4.570

6,749

EmrD

3.589

4.864

1.652

1.680

2.606

1.592

1.827

1.202

5.226

3,040

EurA

1.481

1.431

1.019

1.117

1.286

1.086

1.186

1.085

2.125

20,562

EurB1

3.194

3.535

1.532

1.573

2.355

1.496

1.705

1.157

4.637

6,371

EurB2

3.702

5.541

1.687

1.711

2.678

1.620

1.862

1.225

5.395

2,085

EurC

3.332

3.897

1.574

1.611

2.443

1.530

1.748

1.169

4.843

5,206

SearB

3.455

4.297

1.611

1.644

2.521

1.560

1.786

1.183

5.027

4,168

SearD

3.804

6.506

1.718

1.739

2.744

1.645

1.894

1.258

5.549

1,218

WprA

0.922

1.072

0.855

0.971

0.943

0.954

1.020

1.073

1.319

25,115

WprB1

3.561

4.728

1.644

1.673

2.589

1.585

1.819

1.198

5.184

3,277

WprB2

3.749

5.920

1.701

1.724

2.708

1.631

1.877

1.238

5.466

1,688

WprB3

3.519

4.545

1.631

1.661

2.562

1.575

1.806

1.191

5.122

3,631


Mathers et al. BMC Cancer 2002 2:36   doi:10.1186/1471-2407-2-36

Open Data